Opportunities and challenges: mesenchymal stem cells in the treatment of multiple sclerosis
Author:
Affiliation:
1. Department of Neurology, China-Japan Union hospital of Jilin University, Changchun city, Jilin, P.R. China
Funder
Health research talents Project of Jilin Province
Jilin Province Development and Reform Commission
Publisher
Informa UK Limited
Subject
General Medicine,General Neuroscience
Link
https://www.tandfonline.com/doi/pdf/10.1080/00207454.2022.2042690
Reference108 articles.
1. Multiple sclerosis
2. Diagnosis of multiple sclerosis: progress and challenges
3. Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis
4. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis
5. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs;International Journal of Molecular Sciences;2023-11-25
2. The microRNAs (miRs) overexpressing mesenchymal stem cells (MSCs) therapy in neurological disorders; hope or hype;Biotechnology Progress;2023-08-29
3. Mesenchymal stem cell-derived exosomal microRNA-367–3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2;Biomedicine & Pharmacotherapy;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3